BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16933161)

  • 1. Use of intra-arterial carbon-dioxide-enhanced ultrasonography for guidance of radiofrequency ablation and transcatheter arterial chemoembolization in hepatocellular carcinoma.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    Cardiovasc Intervent Radiol; 2006; 29(6):1111-3. PubMed ID: 16933161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon dioxide-enhanced sonographically guided radiofrequency ablation plus transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Vasc Interv Radiol; 2006 Apr; 17(4):723-6. PubMed ID: 16614157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CO2-enhanced sonographically guided radiofrequency ablation and transcatheter arterial chemoembolization for small hepatocellular carcinoma poorly defined on conventional sonography.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Clin Ultrasound; 2007 Feb; 35(2):78-81. PubMed ID: 17195192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    Hepatogastroenterology; 2005; 52(65):1344-6. PubMed ID: 16201070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
    Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
    J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma supplied from the short gastric artery: treatment with chemoembolization.
    Jeon UB; Lee JW; Baik SK; Kim TU; Choo KS; Kim KI; Kim YW; Moon TY
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1512-4. PubMed ID: 22532333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience.
    Higashihara H; Okazaki M
    Hepatogastroenterology; 2002; 49(43):72-8. PubMed ID: 11941988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
    Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK
    Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with huge hepatocellular carcinoma who had a complete clinical response to p53 gene combined with chemotherapy and transcatheter arterial chemoembolization.
    Tian G; Liu J; Sui J
    Anticancer Drugs; 2009 Jun; 20(5):403-7. PubMed ID: 19318914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter arterial chemoembolization for hepatocellular carcinoma: prospective assessment of the right inferior phrenic artery with C-arm CT.
    Kim HC; Chung JW; Park JH; An S; Son KR; Seong NJ; Jae HJ
    J Vasc Interv Radiol; 2009 Jul; 20(7):888-95. PubMed ID: 19481471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder.
    Clouse ME; Stokes KR; Kruskal JB; Perry LJ; Stuart KE; Nasser IA
    J Vasc Interv Radiol; 1993; 4(6):717-25. PubMed ID: 7506597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features of hepatocellular carcinoma after transcatheter arterial chemoembolization and radiofrequency ablation.
    Lim HS; Jeong YY; Kang HK; Kim JK; Park JG
    AJR Am J Roentgenol; 2006 Oct; 187(4):W341-9. PubMed ID: 16985104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Hashimoto M; Watanabe O; Hirano Y; Kato K; Watarai J
    AJR Am J Roentgenol; 1997 Nov; 169(5):1307-10. PubMed ID: 9353447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for the local recurrent tumor after resection of the adrenal metastasis from hepatocellular carcinoma--a case report].
    Yasumoto T; Hayashi S; Shimizu J; Dono K; Nakata S; Sato M; Kitada M; Shimano T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2371-3. PubMed ID: 20037426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma--CT examination during the follow-up period].
    Sugimori K; Numata K; Morimoto M; Hirao M; Hirasawa K; Oka H; Kokawa A; Shirato K; Saito T; Tanaka K; Imada T; Nozawa A
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1733-6. PubMed ID: 15553698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study.
    Caturelli E; Siena DA; Fusilli S; Villani MR; Schiavone G; Nardella M; Balzano S; Florio F
    Radiology; 2000 Apr; 215(1):123-8. PubMed ID: 10751477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency.
    Geschwind JF; Ramsey DE; Cleffken B; van der Wal BC; Kobeiter H; Juluru K; Hartnell GG; Choti MA
    Cardiovasc Intervent Radiol; 2003; 26(2):111-7. PubMed ID: 12616414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen.
    Kim YS; Rhim H; Lim HK; Park CK; Lee WJ; Do YS; Cho JW
    J Comput Assist Tomogr; 2006; 30(4):578-82. PubMed ID: 16845287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.